Drug intelligence / Profile preview

bone morphogenetic protein 10

Development stage
Preclinical
Lead developer
Taipei Veterans General Hospital
Modality
Recombinant Proteins and Enzymes
Administration
Intraperitoneal
01

Overview

Bone morphogenetic protein 10 (BMP10) is a member of the TGF-β superfamily, primarily synthesized in the right atrium and secreted into the systemic circulation. It plays a critical role in cardiac development and the maintenance of postnatal cardiac function. Recent research, such as that presented at ATS 2026, suggests that recombinant BMP10 may have therapeutic potential in treating pulmonary fibrosis. It appears to mitigate fibrotic progression by suppressing epithelial-mesenchymal transition (EMT), endothelial-mesenchymal transition (EndoMT), and fibroblast-to-myofibroblast differentiation (FMD), likely through the inhibition of the TGF-β/Smad2 signaling pathway.

Other names
BMP-10BMP10BMP 10
02

Targets

ENG (Integrin Beta 6)BMPR1BACVR2B (Activin receptor type IIB)ACVR2A (Activin receptor type 2A)BMPR2 (Bone morphogenetic protein receptor type II)BMPR1AACVRL1 (Activin receptor-like kinase 1)

Beyond the preview

Go deeper on bone morphogenetic protein 10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bone morphogenetic protein 10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call